151 related articles for article (PubMed ID: 3337907)
1. Plasma cell karyotype in multiple myeloma.
Gould J; Alexanian R; Goodacre A; Pathak S; Hecht B; Barlogie B
Blood; 1988 Feb; 71(2):453-6. PubMed ID: 3337907
[TBL] [Abstract][Full Text] [Related]
2. Multiple chromosomal abnormalities in fulminant anaplastic myeloma.
Maslovsky I; Lugassy G; Blumental R; Ducach A; Yehuda O; Abeliovich D
Clin Lab Haematol; 1999 Jun; 21(3):207-10. PubMed ID: 10448603
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cytogenetics in multiple myeloma.
Seong C; Delasalle K; Hayes K; Weber D; Dimopoulos M; Swantkowski J; Huh Y; Glassman A; Champlin R; Alexanian R
Br J Haematol; 1998 Apr; 101(1):189-94. PubMed ID: 9576200
[TBL] [Abstract][Full Text] [Related]
4. Der(16)t(1;16)(q10;p10) in multiple myeloma: a new non-random abnormality that is frequently associated with Burkitt's-type translocations.
Mugneret F; Sidaner I; Favre B; Manone L; Maynadié M; Caillot D; Solary E
Leukemia; 1995 Feb; 9(2):277-81. PubMed ID: 7869764
[TBL] [Abstract][Full Text] [Related]
5. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.
Gutiérrez NC; Hernández JM; García JL; Almeida J; Mateo G; González MI; Hernández J; Fernández-Calvo J; San Miguel JF
Haematologica; 2000 Nov; 85(11):1146-52. PubMed ID: 11064466
[TBL] [Abstract][Full Text] [Related]
6. Karyotypic evolution in multiple myeloma.
MacKenzie MR; Lewis JP
Cancer Genet Cytogenet; 1985 Aug; 17(4):301-5. PubMed ID: 4016715
[TBL] [Abstract][Full Text] [Related]
7. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I
Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778
[TBL] [Abstract][Full Text] [Related]
8. Karyotype in multiple myeloma and plasma cell leukaemia.
Weh HJ; Gutensohn K; Selbach J; Kruse R; Wacker-Backhaus G; Seeger D; Fiedler W; Fett W; Hossfeld DK
Eur J Cancer; 1993; 29A(9):1269-73. PubMed ID: 8343266
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic findings in 200 patients with multiple myeloma.
Sawyer JR; Waldron JA; Jagannath S; Barlogie B
Cancer Genet Cytogenet; 1995 Jul; 82(1):41-9. PubMed ID: 7627933
[TBL] [Abstract][Full Text] [Related]
10. Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia.
Taniwaki M; Nishida K; Takashima T; Nakagawa H; Fujii H; Tamaki T; Shimazaki C; Horiike S; Misawa S; Abe T
Blood; 1994 Oct; 84(7):2283-90. PubMed ID: 7919347
[TBL] [Abstract][Full Text] [Related]
11. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma.
Rao PH; Cigudosa JC; Ning Y; Calasanz MJ; Iida S; Tagawa S; Michaeli J; Klein B; Dalla-Favera R; Jhanwar SC; Ried T; Chaganti RS
Blood; 1998 Sep; 92(5):1743-8. PubMed ID: 9716604
[TBL] [Abstract][Full Text] [Related]
12. Dissecting karyotypic patterns in non-hyperdiploid multiple myeloma: an overview on the karyotypic evolution.
Jimenez-Zepeda VH; Braggio E; Fonseca R
Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):552-8. PubMed ID: 23856591
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma and acute myelomonocytic leukemia: simultaneous occurrence without previous chemotherapy.
Annino L; Martino P; Barsotti P; Serra P; Marinozzi V; Mandelli F
Acta Haematol; 1980; 64(4):195-200. PubMed ID: 6781197
[TBL] [Abstract][Full Text] [Related]
14. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
Nishida K; Tamura A; Nakazawa N; Ueda Y; Abe T; Matsuda F; Kashima K; Taniwaki M
Blood; 1997 Jul; 90(2):526-34. PubMed ID: 9226151
[TBL] [Abstract][Full Text] [Related]
15. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.
Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A
Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic study of 30 patients with multiple myeloma: comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method.
Brigaudeau C; Trimoreau F; Gachard N; Rouzier E; Jaccard A; Bordessoule D; Praloran V
Br J Haematol; 1997 Mar; 96(3):594-600. PubMed ID: 9054668
[TBL] [Abstract][Full Text] [Related]
17. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.
Debes-Marun CS; Dewald GW; Bryant S; Picken E; Santana-Dávila R; González-Paz N; Winkler JM; Kyle RA; Gertz MA; Witzig TE; Dispenzieri A; Lacy MQ; Rajkumar SV; Lust JA; Greipp PR; Fonseca R
Leukemia; 2003 Feb; 17(2):427-36. PubMed ID: 12592343
[TBL] [Abstract][Full Text] [Related]
18. Multiple myeloma with discordant M components in the serum and CSF.
Dotten DA; Pruzanski W
Arch Intern Med; 1981 Sep; 141(10):1374-6. PubMed ID: 6791605
[TBL] [Abstract][Full Text] [Related]
19. Non-random chromosomal aberrations associated with multiple myeloma.
Lewis JP; MacKenzie MR
Hematol Oncol; 1984; 2(4):307-17. PubMed ID: 6335483
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma.
Rajkumar SV; Fonseca R; Dewald GW; Therneau TM; Lacy MQ; Kyle RA; Greipp PR; Gertz MA
Cancer Genet Cytogenet; 1999 Aug; 113(1):73-7. PubMed ID: 10459351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
